[The metabolic syndrome and hyper-Lp(a)-lipoproteinemia in peripheral obliterative atherosclerosis: 2 case reports].
One of the characteristics of peripheral vascular disease in diabetic patients is that it occurs at the time of detection of diabetes mellitus. As one of the possible pathogenic mechanisms, in non-smokers, is the sol-called metabolic syndrome (obesity, disorders in regard to metabolism of lipids and carbohydrates and hypertension). Lipoprotein Lp(a) is the most atherogenic among lipoproteins. While data on coronary arterial disease exist, although contradictory, there is a small number of those which document the same for peripheral vascular occlusive disease in diabetics. Two patients, non-smokers, with characteristic constellation of risk factors, are described as possible models for further epidemiologic examinations.
Tesić
D
D
Klinika za endokrinologiju, dijabetes i bolesti metabolizma, Institut za interne bolesti, Medicinski fakultet, Novi Sad.
Derić
M
M
Ivković-Lazar
T
T
Pantelinac
P
P
Lepsanović
L
L
D001162:Arteriosclerosis Obliterans / Q000150:complications*; D048909:Diabetes Complications; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D005260:Female; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood / Q000150:complications*; D017270:Lipoprotein(a) / Q000097:blood*; D008875:Middle Aged; D009765:Obesity
D017270:Lipoprotein(a)